Monounsaturated fats

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: heart inflammation weight

Research Overview

Research on monounsaturated fats (MUFAs) has been most extensively conducted in the context of overall dietary patterns—particularly the Mediterranean diet—rather than as isolated nutrients. Across observational cohorts and randomized trials of Mediterranean-style diets, MUFA-rich foods (especially extra virgin olive oil) are repeatedly embedded within broader dietary exposures that also include high intakes of fruits, vegetables, legumes, whole grains, nuts, and fish. Consequently, much of the evidence base evaluates MUFAs as part of a dietary matrix that also provides fiber and polyphenols, with outcomes spanning cardiovascular risk factors and events, metabolic health, inflammation-related biomarkers, and, more recently, gut microbiome composition. Clinical guidance in inflammatory bowel disease (IBD) similarly emphasizes Mediterranean-style eating patterns that are “rich in…monounsaturated fats” for overall health, while noting that no diet has consistently reduced flare rates in adults with IBD.

The strongest evidence supports MUFA-rich Mediterranean dietary patterns as beneficial for cardiovascular health, with consistent associations and trial data showing improvements in intermediate cardiometabolic markers (e.g., lipids, waist-to-hip ratio, inflammatory markers) and evidence—strongest at the dietary-pattern level—suggesting reductions in cardiovascular morbidity and mortality. Beyond cardiovascular endpoints, reviews synthesize observational and experimental findings linking Mediterranean-style patterns to lower risk of several chronic conditions (e.g., diabetes, obesity, some cancers, cognitive decline), though the degree to which MUFAs specifically drive these effects versus co-occurring components (polyphenols, fiber, overall food quality) remains uncertain. In IBD, expert guidance supports Mediterranean-style diets for general well-being and nutritional adequacy, but the evidence does not support MUFA-focused dietary modification as a reliable strategy to prevent disease flares; instead, nutrition therapies such as enteral nutrition have more direct evidence for inducing remission in Crohn’s disease.

Key gaps include disentangling the independent effects of MUFAs from the broader Mediterranean dietary pattern and from specific food sources (e.g., olive oil vs nuts vs animal-derived MUFAs), as well as establishing more “hard” clinical endpoints attributable to MUFA exposure in diverse populations. More randomized trials are needed that isolate MUFA substitution effects (e.g., replacing saturated fats or refined carbohydrates with MUFAs) while controlling for accompanying bioactives and overall diet quality, and that measure clinical outcomes rather than only surrogate biomarkers. Additional research is also needed on mechanistic pathways—particularly microbiome-mediated effects—and on disease-specific outcomes such as IBD activity, where current guidance favors Mediterranean patterns for health and malnutrition prevention but lacks consistent evidence for flare reduction attributable to MUFAs.

1. What conditions has Monounsaturated fats been studied for?

  • Inflammatory bowel disease (IBD) (including Crohn’s disease and ulcerative colitis) in the context of overall dietary patterns (Mediterranean diet rich in monounsaturated fats).

  • Cardiovascular disease (CVD) prevention (primary prevention in people without established CVD or at high risk; secondary prevention in people with established coronary heart disease), largely via Mediterranean-style dietary interventions characterized by a high monounsaturated-to-saturated fat ratio (often from olive oil and/or nuts).

  • Stroke as a specific cardiovascular endpoint (reported within a Mediterranean diet trial context).

  • Cardiometabolic risk factors (surrogate outcomes), including blood lipids (total cholesterol, LDL, HDL, triglycerides) and blood pressure.

  • Gut microbiome modulation (Mediterranean diet pattern described as fostering beneficial gut bacteria; details are truncated in the study excerpt).

  • Other conditions mentioned in a narrative review as being reduced in burden/risk with Mediterranean diet patterns that include monounsaturated fats: breast cancer, depression, colorectal cancer, diabetes, obesity, asthma, erectile dysfunction, and cognitive decline (these are attributed to the overall Mediterranean diet pattern rather than isolated monounsaturated fats).

2. Does it work in treating those conditions? Summarize the evidence.

  • IBD (Crohn’s disease/ulcerative colitis): The AGA Clinical Practice Update advises a Mediterranean diet “unless contraindicated,” describing it as beneficial for overall health and well-being in IBD. However, it also states that no diet has consistently been found to decrease the rate of flares in adults with IBD. Thus, evidence in these studies supports Mediterranean-style eating (including monounsaturated fats) for general health in IBD, but not as a consistently proven flare-prevention treatment.

  • Primary prevention of CVD (clinical endpoints): In the Cochrane review, most primary-prevention trials did not report clinical endpoints. In PREDIMED (Mediterranean diet advice plus extra-virgin olive oil or nuts vs low-fat diet; retracted and re-analyzed due to randomization concerns), there was low-quality evidence of little or no effect on CVD mortality (HR 0.81, 95% CI 0.50 to 1.32) or total mortality (HR 1.0, 95% CI 0.81 to 1.24) over 4.8 years, but a reduction in stroke (HR 0.60, 95% CI 0.45 to 0.80; moderate-quality evidence).

  • Primary prevention of CVD (risk factors): The Cochrane review found modest improvements in some surrogates. Examples include reductions in systolic blood pressure (~ -2.99 mmHg) and diastolic blood pressure (~ -2.0 mmHg) in one comparison, and small reductions in LDL cholesterol (-0.15 mmol/L) and triglycerides (-0.09 mmol/L) in another. Evidence quality ranged from low to moderate, and effects were generally small.

  • Secondary prevention (established CHD): The Lyon Diet Heart Study (Mediterranean diet advice plus canola margarine vs usual care) showed low-quality evidence of reduced CVD mortality (HR 0.35, 95% CI 0.15 to 0.82) and total mortality (HR 0.44, 95% CI 0.21 to 0.92) over 46 months. However, the Cochrane review notes limited trial evidence overall for secondary prevention and uncertainty in some comparisons.

  • Gut microbiome: One abstract states the Mediterranean diet modulates gut microbiota and fosters beneficial bacteria, but the excerpt provided is incomplete and does not provide specific organisms, effect sizes, or clinical outcomes. Based on the provided text alone, this is suggestive but not quantifiable.

  • Important limitation across studies: Much of the evidence is for Mediterranean dietary patterns (multi-component interventions), not monounsaturated fats in isolation. Therefore, causality attributable specifically to monounsaturated fats cannot be firmly established from these studies.

3. What health benefits does it have?

  • Supports a Mediterranean dietary pattern associated with broad health benefits: The AGA CPU recommends a Mediterranean diet rich in monounsaturated fats for overall health and well-being in IBD (with practical accommodations for strictures/obstruction when needed).

  • Stroke risk reduction (in a Mediterranean diet intervention): In the re-analyzed PREDIMED trial, Mediterranean diet advice plus extra-virgin olive oil or nuts reduced stroke (HR 0.60, 95% CI 0.45 to 0.80; moderate-quality evidence).

  • Modest improvements in cardiovascular risk factors: Evidence from the Cochrane review suggests small reductions in blood pressure (about 2–3 mmHg systolic and ~2 mmHg diastolic in one comparison) and small reductions in LDL cholesterol and triglycerides in some comparisons.

  • Potential anti-inflammatory/metabolic benefits (pattern-level): A narrative review notes improvements in markers of inflammation and other surrogates (e.g., waist-to-hip ratio, lipids) with Mediterranean diet patterns that include monounsaturated fats, though it also highlights uncertainty about whether benefits come from individual components or the overall pattern.

  • Potential gut microbiome benefits (pattern-level): One abstract describes the Mediterranean diet (high in monounsaturated fats and polyphenols, especially from extra-virgin olive oil) as fostering beneficial gut bacteria, which may plausibly relate to metabolic and inflammatory health, but specific evidence details are not provided in the excerpt.

4. Does it have any downsides or side effects?

  • Adverse events appear uncommon in Mediterranean diet trials: The Cochrane review notes that two trials reported adverse events and that these were absent or minor (low- to moderate-quality evidence).

  • IBD-specific tolerability issues may require dietary modification: The AGA CPU notes that patients with IBD and symptomatic intestinal strictures may not tolerate fibrous plant foods due to texture; while this is not a downside of monounsaturated fats per se, it affects how a Mediterranean-style pattern is implemented (e.g., cooking/processing fruits and vegetables to softer textures).

  • Unclear component-specific harms: These studies do not identify specific harms attributable to monounsaturated fats alone (e.g., olive oil) separate from overall dietary patterns. Also, the narrative review explicitly notes uncertainty about whether benefits are due to individual constituents versus the aggregate diet, which similarly limits conclusions about constituent-specific risks.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic findings (e.g., gene–diet interactions) related to monounsaturated fats or Mediterranean diet interventions. Therefore, based on these studies alone, it is not possible to conclude whether monounsaturated fats are specifically beneficial or harmful for particular genetic variants.

References

  1. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Jana G Hashash, Jaclyn Elkins, James D Lewis, David G Binion (2024) - Gastroenterology
  2. The Mediterranean diet, its components, and cardiovascular disease.
    R Jay Widmer, Andreas J Flammer, Lilach O Lerman, Amir Lerman (2015) - The American journal of medicine
  3. Gut Microbiota Modulation Through Mediterranean Diet Foods: Implications for Human Health.
    Pasquale Perrone, Stefania D'Angelo (2025) - Nutrients
  4. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.
    Karen Rees, Andrea Takeda, Nicole Martin, Leila Ellis, Dilini Wijesekara, Abhinav Vepa, Archik Das, Louise Hartley, Saverio Stranges (2019) - The Cochrane database of systematic reviews
  5. Reduction in saturated fat intake for cardiovascular disease.
    Lee Hooper, Nicole Martin, Asmaa Abdelhamid, George Davey Smith (2015) - The Cochrane database of systematic reviews
  6. The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review.
    Vincenzo Abrignani, Andrea Salvo, Gaetano Pacinella, Antonino Tuttolomondo (2024) - International journal of molecular sciences
  7. The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management.
    Genoveva Berná, Manuel Romero-Gomez (2020) - Liver international : official journal of the International Association for the Study of the Liver
  8. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility.
    Sara Paola Mambrini, Antonio Grillo, Santo Colosimo, Francesco Zarpellon, Giorgia Pozzi, Davide Furlan, Gabriele Amodeo, Simona Bertoli (2024) - Frontiers in nutrition
  9. The Role of Diet in the Pathogenesis of Cholesterol Gallstones.
    Agostino Di Ciaula, Gabriella Garruti, Gema Frühbeck, Maria De Angelis, Ornella de Bari, David Q-H Wang, Frank Lammert, Piero Portincasa (2019) - Current medicinal chemistry
  10. Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases?
    Carmela Santangelo, Rosariax Vari, Beatrice Scazzocchio, Patrizia De Sanctis, Claudio Giovannini, Massimo D'Archivio, Roberta Masella (2018) - Endocrine, metabolic & immune disorders drug targets
  11. Monounsaturated fats from plant and animal sources in relation to risk of coronary heart disease among US men and women.
    Geng Zong, Yanping Li, Laura Sampson, Lauren W Dougherty, Walter C Willett, Anne J Wanders, Marjan Alssema, Peter L Zock, Frank B Hu, Qi Sun (2018) - The American journal of clinical nutrition
  12. Nutrition and physical activity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022.
    Lydia Alexander, Sandra M Christensen, Larry Richardson, Amy Beth Ingersoll, Karli Burridge, Angela Golden, Sara Karjoo, Danielle Cortez, Michael Shelver, Harold Edward Bays (2022) - Obesity pillars
  13. Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies.
    Andrea J Glenn, Marta Guasch-Ferré, Vasanti S Malik, Cyril W C Kendall, JoAnn E Manson, Eric B Rimm, Walter C Willett, Qi Sun, David J A Jenkins, Frank B Hu, John L Sievenpiper (2023) - Circulation
  14. The Effects of Almond Consumption on Cardiovascular Health and Gut Microbiome: A Comprehensive Review.
    Saiful Singar, Saurabh Kadyan, Cole Patoine, Gwoncheol Park, Bahram Arjmandi, Ravinder Nagpal (2024) - Nutrients
  15. Diets for Health: Goals and Guidelines.
    Amy Locke, Jill Schneiderhan, Suzanna M Zick (2018) - American family physician
  16. Diet and female fertility: doctor, what should I eat?
    Yu-Han Chiu, Jorge E Chavarro, Irene Souter (2018) - Fertility and sterility


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!